Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

ReNerve Quarterly Sales Top Full-Year FY26 Result

ReNerve Limited (RNV) · Health care

RNV: $0.089 -1.11% · MC: $14M

ReNerve reported record quarterly sales of approximately $584,000, up 176% on the previous quarter and 774% on the same quarter last year, exceeding its FY26 full-year sales. September was its first month with sales above $200,000; cash was approximately $2 million at quarter-end, with the company reporting 4.5 quarters of funding available including its undrawn facility.

Source announcements: 2026-11-02 10:36 to 2026-11-02 10:36 Sydney time
Story updated 2026-11-02 10:42 Sydney time
SourcesQuarterly Investor Presentation
Comments